Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer
Siqi Huang,1 Zheyu Zhang,1 Wenqun Li,2 Fanhua Kong,3 Pengji Yi,1 Jianhua Huang,4 Dan Mao,1 Weijun Peng,1 Sifang Zhang1 1Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People’s Republic...
Main Authors: | Huang S, Zhang Z, Li W, Kong F, Yi P, Huang J, Mao D, Peng W, Zhang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/network-pharmacology-based-prediction-and-verification-of-the-active-i-peer-reviewed-article-DDDT |
Similar Items
-
Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
by: Guohua Yu, et al.
Published: (2018-11-01) -
Isoliquiritigenin inhibits colorectal cancer cells HCT-116 growth by suppressing the PI3K/AKT pathway
by: Huang Ya-Li, et al.
Published: (2017-10-01) -
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
by: Liu J, et al.
Published: (2021-07-01) -
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
by: Lin Li, et al.
Published: (2020-04-01) -
Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation
by: Yirixiati Aihaiti, et al.
Published: (2021-05-01)